Warren Buffett stoked hopes of a transformation at the world’s biggest generic drugmaker as his Berkshire Hathaway Inc. became a top shareholder weeks after pledging to cut soaring U.S. health-care costs.
Shares of the drugmaker, Israel’s troubled Teva Pharmaceutical Industries Ltd., surged the most in two months after Berkshire disclosed it had bought about $350 million worth of stock.